CD4 and histiocytic sarcoma: Giudici et al. found that in both patients with HS and CD, significantly higher CD4+ and CD16+ T-lymphocytes counts in CD fistulas and HS lesions, supporting a potential role in the pathogenesis of both immune conditions (Giudici, [3]).